9426 related articles for article (PubMed ID: 11776489)
1. Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy.
Dessureault S; Soong SJ; Ross MI; Thompson JF; Kirkwood JM; Gershenwald JE; Coit DG; McMasters KM; Balch CM; Reintgen D;
Ann Surg Oncol; 2001 Dec; 8(10):766-70. PubMed ID: 11776489
[TBL] [Abstract][Full Text] [Related]
2. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma.
Doubrovsky A; De Wilt JH; Scolyer RA; McCarthy WH; Thompson JF
Ann Surg Oncol; 2004 Sep; 11(9):829-36. PubMed ID: 15313732
[TBL] [Abstract][Full Text] [Related]
3. Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (> or = 4 mm) primary melanoma.
Gershenwald JE; Mansfield PF; Lee JE; Ross MI
Ann Surg Oncol; 2000 Mar; 7(2):160-5. PubMed ID: 10761797
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant therapy of malignant melanoma and the role of sentinel node mapping.
Eggermont AM
Recent Results Cancer Res; 2000; 157():178-89. PubMed ID: 10857171
[TBL] [Abstract][Full Text] [Related]
5. Regional lymph node dissections in malignant melanoma.
Lawton GP; Ariyan S
Clin Plast Surg; 2000 Jul; 27(3):431-40, ix. PubMed ID: 10941563
[TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of elective lymph node dissection in malignant melanoma of the extremities and trunk. An analysis in view of the sentinel lymph node biopsy].
Zimmermann T; Andresen S; Schmitt H; Padberg W
Zentralbl Chir; 2001 Apr; 126(4):279-82. PubMed ID: 11370389
[TBL] [Abstract][Full Text] [Related]
8. Morbidity and outcome after sentinel lymph node dissection in patients with early-stage malignant cutaneous melanoma.
Blumenthal R; Banic A; Brand CU; Ris HB; Lardinois D
Swiss Surg; 2002; 8(5):209-14. PubMed ID: 12422766
[TBL] [Abstract][Full Text] [Related]
9. Early recurrence after lymphatic mapping and sentinel node biopsy in patients with primary extremity melanoma: a comparison with elective lymph node dissection.
Clary BM; Mann B; Brady MS; Lewis JJ; Coit DG
Ann Surg Oncol; 2001 May; 8(4):328-37. PubMed ID: 11352306
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node staging of cutaneous melanoma: predictors and outcomes.
Ellis MC; Weerasinghe R; Corless CL; Vetto JT
Am J Surg; 2010 May; 199(5):663-8. PubMed ID: 20466113
[TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node biopsy for melanoma: indications and rationale.
Phan GQ; Messina JL; Sondak VK; Zager JS
Cancer Control; 2009 Jul; 16(3):234-9. PubMed ID: 19556963
[TBL] [Abstract][Full Text] [Related]
12. Sentinel node staging of primary melanoma by the "10% rule": pathology and clinical outcomes.
Emery RE; Stevens JS; Nance RW; Corless CL; Vetto JT
Am J Surg; 2007 May; 193(5):618-22; discussion 622. PubMed ID: 17434368
[TBL] [Abstract][Full Text] [Related]
13. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.
Wat H; Senthilselvan A; Salopek TG
J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815
[TBL] [Abstract][Full Text] [Related]
14. The long-term results and prognostic significance of cutaneous melanoma surgery using sentinel node biopsy with triple technique.
Rutkowski P; Szydłowski K; Nowecki ZI; Sałamacha M; Goryń T; Mitręga-Korab B; Pieńkowski A; Dziewirski W; Zdzienicki M
World J Surg Oncol; 2015 Oct; 13():299. PubMed ID: 26462471
[TBL] [Abstract][Full Text] [Related]
15. The effect of the AJCC 7th edition change in T1 melanoma substaging on national utilization and outcomes of sentinel lymph node biopsy for thin melanoma.
Hieken TJ; Grotz TE; Comfere NI; Inselman JW; Habermann EB
Melanoma Res; 2015 Apr; 25(2):157-63. PubMed ID: 25647736
[TBL] [Abstract][Full Text] [Related]
16. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients.
Gershenwald JE; Thompson W; Mansfield PF; Lee JE; Colome MI; Tseng CH; Lee JJ; Balch CM; Reintgen DS; Ross MI
J Clin Oncol; 1999 Mar; 17(3):976-83. PubMed ID: 10071292
[TBL] [Abstract][Full Text] [Related]
17. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU
Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
[TBL] [Abstract][Full Text] [Related]
18. Sentinel node biopsy versus elective lymph node dissection in patients with cutaneous melanoma in a Japanese population.
Tsutsumida A; Furukawa H; Yamamoto Y; Horiuchi K; Yoshida T; Minakawa H; Fujii S; Murao N; Kuwahara H; Minamimoto T; Fujioka H; Sakamoto T; Honma T
Int J Clin Oncol; 2007 Aug; 12(4):245-9. PubMed ID: 17701001
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of sentinel lymph node biopsy according to Breslow thickness for cutaneous melanoma.
Stiegel E; Xiong D; Ya J; Funchain P; Isakov R; Gastman B; Vij A
J Am Acad Dermatol; 2018 May; 78(5):942-948. PubMed ID: 29408526
[TBL] [Abstract][Full Text] [Related]
20. Single-institution experience in the management of patients with clinical stage I and II cutaneous melanoma: results of sentinel lymph node biopsy in 240 cases.
Rex J; Paradelo C; Mangas C; Hilari JM; Fernández-Figueras MT; Fraile M; Alastrué A; Ferrándiz C
Dermatol Surg; 2005 Nov; 31(11 Pt 1):1385-93. PubMed ID: 16416605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]